ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 33 filers reported holding ATYR PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $26,000 | -65.8% | 32,230 | +47.6% | 0.00% | – |
| Q4 2017 | $76,000 | -26.2% | 21,842 | -25.8% | 0.00% | – |
| Q1 2017 | $103,000 | +2.0% | 29,427 | -37.7% | 0.00% | – |
| Q4 2016 | $101,000 | -41.3% | 47,197 | -12.9% | 0.00% | – |
| Q3 2016 | $172,000 | +25.5% | 54,200 | +9.6% | 0.00% | – |
| Q2 2016 | $137,000 | -16.5% | 49,453 | +196.2% | 0.00% | – |
| Q4 2015 | $164,000 | – | 16,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $18,755,000 | 12.78% |
| EcoR1 Capital, LLC | 840,462 | $8,623,000 | 3.92% |
| Rock Springs Capital Management LP | 388,996 | $3,991,000 | 0.32% |
| SPHERA FUNDS MANAGEMENT LTD. | 209,027 | $2,145,000 | 0.27% |
| Baker Brothers Advisors | 2,335,125 | $23,958,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 461,530 | $4,735,000 | 0.18% |
| TIVERTON ASSET MANAGEMENT LLC | 472,236 | $4,845,000 | 0.11% |
| RS INVESTMENT MANAGEMENT CO LLC | 1,082,249 | $11,104,000 | 0.10% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 415,377 | $4,262,000 | 0.07% |
| Magnetar Financial LLC | 354,659 | $3,639,000 | 0.05% |